MTPConnect is partnering with biotech companies CSL and Roche Diagnostics to help Australian startups commercialise their CVD and diabetes drugs and devices.
MTPConnect is partnering with biotech companies CSL and Roche Diagnostics to help Australian startups commercialise their CVD and diabetes drugs and devices.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.